• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术拒绝对甲状腺癌生存率的影响:基于监测、流行病学和最终结果(SEER)数据库的分析

The impact of surgery refusal on thyroid cancer survival: a SEER-based analysis.

作者信息

van Gerwen Maaike, Sinclair Catherine, Rahman Maleeha, Genden Eric, Taioli Emanuela

机构信息

Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

出版信息

Endocrine. 2020 Nov;70(2):356-363. doi: 10.1007/s12020-020-02301-9. Epub 2020 Apr 19.

DOI:10.1007/s12020-020-02301-9
PMID:32307656
Abstract

PURPOSE

In the current era of de-escalation of surgical treatment for low-risk thyroid cancer, it is important to ensure that the natural history of thyroid cancer is as benign as has been suggested previously. We therefore compared the impact of surgery refusal and surgery on disease-specific survival (DSS) in patients with local or regional, papillary thyroid cancer (PTC).

METHODS

Local and regional stage PTC patients in the Surveillance, Epidemiology, and End Results Program (1988-2015) were included. Cox proportional hazard modeling and propensity score matching were conducted to evaluate DSS.

RESULTS

There were 45,136 patients who received surgery and 146 patients who had surgery recommended but refused. Adjusted analysis showed a significantly better DSS for the surgery group compared with the refusal group (HR: 3.07 (95% CI: 1.54-6.11). After stratification for stage, no statistically significant difference in DSS was found (HR: 3.03 (0.89-10.35) when including only local stage PTC. Propensity matching showed a 10-year DSS of 94.0% (95% CI: 87.7-97.1%) and 96.4% (95% CI: 93.2-98.1%) for the refusal and surgery group (p = 0.060). Propensity matching of local stage PTC showed a 10-year DSS of 96.7% (95% CI: 89.9-98.9%) and 100%, respectively (p = 0.002).

CONCLUSION

Although no significant difference in survival was found between surgery and no surgery in local stage PTC, a 3.3% improvement of 10-year DSS was found in the surgery group. Overall, these results suggest that local stage PTC has a benign natural history, and that conservative management strategies such as active surveillance may be appropriate.

摘要

目的

在当前低风险甲状腺癌手术治疗降阶梯的时代,确保甲状腺癌的自然病程如先前所示那般良性是很重要的。因此,我们比较了局部或区域乳头状甲状腺癌(PTC)患者拒绝手术和接受手术对疾病特异性生存(DSS)的影响。

方法

纳入监测、流行病学和最终结果计划(1988 - 2015年)中的局部和区域分期PTC患者。进行Cox比例风险建模和倾向评分匹配以评估DSS。

结果

有45136例患者接受了手术,146例患者被建议手术但拒绝了。校正分析显示,与拒绝手术组相比,手术组的DSS明显更好(风险比:3.07(95%置信区间:1.54 - 6.11))。按分期分层后,仅纳入局部分期PTC时,DSS未发现统计学上的显著差异(风险比:3.03(0.89 - 10.35))。倾向匹配显示,拒绝手术组和手术组的10年DSS分别为94.0%(95%置信区间:87.7 - 97.1%)和96.4%(95%置信区间:93.2 - 98.1%)(p = 0.060)。局部分期PTC的倾向匹配显示,10年DSS分别为96.7%(95%置信区间:89.9 - 98.9%)和100%(p = 0.002)。

结论

虽然局部分期PTC患者手术和未手术之间在生存方面未发现显著差异,但手术组的10年DSS提高了3.3%。总体而言,这些结果表明局部分期PTC具有良性自然病程,积极监测等保守管理策略可能是合适的。

相似文献

1
The impact of surgery refusal on thyroid cancer survival: a SEER-based analysis.手术拒绝对甲状腺癌生存率的影响:基于监测、流行病学和最终结果(SEER)数据库的分析
Endocrine. 2020 Nov;70(2):356-363. doi: 10.1007/s12020-020-02301-9. Epub 2020 Apr 19.
2
Survival benefit of active surveillance for papillary thyroid carcinoma: a propensity score matching analysis based on SEER database.甲状腺乳头状癌主动监测的生存获益:基于监测、流行病学与最终结果(SEER)数据库的倾向评分匹配分析
Front Oncol. 2023 Jun 9;13:1185650. doi: 10.3389/fonc.2023.1185650. eCollection 2023.
3
Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.非手术治疗甲状腺乳头状癌的死亡率:主动监测的推论。
Thyroid. 2019 Oct;29(10):1409-1417. doi: 10.1089/thy.2019.0060. Epub 2019 Sep 24.
4
Management of Very Elderly Patients With Papillary Thyroid Cancer: Analysis of Outcomes for Surgery Versus Nonsurgery.高龄甲状腺乳头状癌患者的管理:手术与非手术治疗结局的分析。
J Surg Res. 2020 Dec;256:512-519. doi: 10.1016/j.jss.2020.07.017. Epub 2020 Aug 13.
5
Delay in Surgery and Papillary Thyroid Cancer Survival in the United States: A SEER-Medicare Analysis.美国手术延迟与甲状腺乳头状癌生存:一项 SEER-医疗保险分析。
J Clin Endocrinol Metab. 2023 Sep 18;108(10):2589-2596. doi: 10.1210/clinem/dgad163.
6
Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.预测甲状腺乳头状癌患者的生存情况:在两个当代国家患者队列中比较第七版和第八版美国癌症联合委员会/国际癌症控制联合会分期系统。
Thyroid. 2017 Nov;27(11):1408-1416. doi: 10.1089/thy.2017.0306. Epub 2017 Oct 5.
7
Low-Risk Thyroid Cancer in Elderly: Total Thyroidectomy/RAI Predominates but Lacks Survival Advantage.老年低危甲状腺癌:全甲状腺切除术/放射性碘治疗占主导地位,但缺乏生存优势。
J Surg Res. 2019 Nov;243:189-197. doi: 10.1016/j.jss.2019.05.029. Epub 2019 Jun 8.
8
Surgery for papillary thyroid carcinoma: is lobectomy enough?甲状腺乳头状癌手术:肺叶切除术足够了吗?
Arch Otolaryngol Head Neck Surg. 2010 Nov;136(11):1055-61. doi: 10.1001/archoto.2010.181.
9
Impact of Age on the Prognosis of Papillary Thyroid Carcinoma.年龄对甲状腺乳头状癌预后的影响
Arch Iran Med. 2020 Mar 1;23(3):169-174.
10
Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.36725例患者中乳头状甲状腺癌和滤泡状甲状腺癌生存率的比较。
Ann Otol Rhinol Laryngol. 2014 Feb;123(2):94-100. doi: 10.1177/0003489414523563.

引用本文的文献

1
Impact of delayed surgery in differentiated thyroid carcinoma and medullary thyroid carcinoma.延迟手术对分化型甲状腺癌和髓样甲状腺癌的影响。
Endocrine. 2025 Apr 24. doi: 10.1007/s12020-025-04241-8.
2
Propensity analysis reveals survival disparities between T1a and T1b well-differentiated thyroid cancer based on surgery.倾向分析显示,基于手术的T1a和T1b高分化甲状腺癌之间存在生存差异。
Gland Surg. 2024 Dec 31;13(12):2335-2347. doi: 10.21037/gs-24-327. Epub 2024 Dec 27.
3
Natural History and Prognostic Model of Untreated Papillary Thyroid Cancer: A SEER Database Analysis.
未治疗的甲状腺乳头状癌的自然史和预后模型:SEER 数据库分析。
Cancer Control. 2024 Jan-Dec;31:10732748241253956. doi: 10.1177/10732748241253956.
4
Navigating Choices: Determinants and Outcomes of Surgery Refusal in Thyroid Cancer Patients Using SEER Data.选择的导航:利用监测、流行病学与结果(SEER)数据探究甲状腺癌患者拒绝手术的决定因素及后果
Cancers (Basel). 2023 Jul 20;15(14):3699. doi: 10.3390/cancers15143699.
5
Bilateral multifocality is an independent predictor of patients' outcome in Middle Eastern papillary thyroid carcinoma.双侧多灶性是中东地区甲状腺乳头状癌患者预后的独立预测因素。
Front Endocrinol (Lausanne). 2023 Jan 4;13:1060301. doi: 10.3389/fendo.2022.1060301. eCollection 2022.
6
Refusal of Surgery in Pituitary Adenoma Patients: A Population-Based Analysis.垂体腺瘤患者拒绝手术治疗:一项基于人群的分析。
Cancers (Basel). 2022 Oct 30;14(21):5348. doi: 10.3390/cancers14215348.
7
Factors Associated With Patient's Refusal of Recommended Cancer Surgery: Based on Surveillance, Epidemiology, and End Results.与患者拒绝推荐的癌症手术相关的因素:基于监测、流行病学和最终结果。
Front Public Health. 2022 Jan 17;9:785602. doi: 10.3389/fpubh.2021.785602. eCollection 2021.
8
Yield and costs of molecular diagnostics on thyroid cytology slides in the Netherlands, adapting the Bethesda classification.荷兰基于 Bethesda 分类法的甲状腺细胞学涂片分子诊断的产量和成本。
Endocrinol Diabetes Metab. 2021 Oct;4(4):e00293. doi: 10.1002/edm2.293. Epub 2021 Sep 2.
9
Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: demonstrating the natural progression of a rare and misunderstood disease.甲状腺嗜酸性硬化性黏液表皮样癌:展示一种罕见且易被误解疾病的自然病程。
BMJ Case Rep. 2021 Jul 26;14(7):e241086. doi: 10.1136/bcr-2020-241086.